Marasco Dominic 4

What Happened Dominic Marasco, President of the Endocrine Business Unit at MannKind Corporation (MNKD), acquired 8,474 shares on May 20, 2026 at $2.95 per share, for a total value of approximately $24,998. The transaction is reported on a Form 4 filed May 22, 2026 and is recorded as an award/acquisition (code A).

Key Details

• Transaction date: May 20, 2026; filing date: May 22, 2026 (filed within the typical two-business-day window).
• Shares acquired: 8,474 at $2.95 per share; total value ≈ $24,998.
• Acquisition method: Purchased through the issuer's Market Price Stock Purchase Plan (per footnote F1); Board approved the purchase on May 20, 2026.
• Footnote F2: Filing notes 2,343 shares were acquired under the issuer's Employee Stock Purchase Plan on December 31, 2025.
• Shares owned after the transaction: Not specified in the provided filing extract.

Context This was a purchase/acquisition under a company stock purchase plan rather than an open-market trade or option exercise. Such purchases can be interpreted as routine plan activity; purchases are often watched by investors as a potential positive signal, but filings do not state the insider’s motivation.